NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹0.40 Cr | ₹15 Cr | ₹8.00 Cr | ₹1.20 Cr | ₹1.10 Cr |
What is the latest Contingent Liabilities ratio of NATCO PHARMA ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹0.40 Cr |
Mar2023 | ₹15 Cr |
Mar2022 | ₹8.00 Cr |
Mar2021 | ₹1.20 Cr |
Mar2020 | ₹1.10 Cr |
How is Contingent Liabilities of NATCO PHARMA Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹0.40 Cr | -97.26 | |
Mar2023 | ₹15 Cr | 82.50 | |
Mar2022 | ₹8.00 Cr | 566.67 | |
Mar2021 | ₹1.20 Cr | 9.09 | |
Mar2020 | ₹1.10 Cr | - |
Compare Contingent Liabilities of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹15,070.4 Cr | -5.8% | 3.6% | -13.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹438,778.0 Cr | 1.4% | 4.1% | 18.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,949.0 Cr | -2.1% | 4.2% | 59.1% | Stock Analytics | |
CIPLA | ₹123,222.0 Cr | -0.1% | 5% | 9.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,205.0 Cr | -0.3% | 3% | 23.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,707.7 Cr | -1.5% | 1.7% | -5.4% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | -5.8% |
3.6% |
-13.6% |
SENSEX | 0.9% |
4.2% |
8.3% |
You may also like the below Video Courses